Where does Ian B. Li work?

Ian B. Li is Principal at 1315 Capital.

What does Ian B. Li invest in?

Ian B. Li invests in Biotech, Healthtech, Medical Devices.

Where did Ian B. Li go to school?

Ian B. Li studied at Duke University (BSE, Biomedical Engineering, Economics).

Ian B. Li

Investor

Principal at 1315 Capital

Philadelphia, Pennsylvania, United States

About

Ian Li joined 1315 Capital in 2015 and is a Principal on the investment team. Before moving into investing, he worked as a healthcare management and strategy consultant at Capgemini Consulting and in quality engineering at Stryker Orthopaedics. He holds a BSE in Biomedical Engineering with an Economics minor from Duke University.

Contact· self-published, not guessed

i•••@1315capital.comreveal

Invests in

BiotechHealthtechMedical Devices

Experience

1315 CapitalPrincipalcurrent2022 — present
1315 CapitalVice President2018 — 2022
1315 CapitalSenior Associate2017 — 2018
1315 CapitalAssociate2015 — 2017
CortiCareBoard Membercurrent2023 — present
3B ScientificBoard Membercurrent2022 — present
miraDry, Inc.Board Membercurrent2021 — present
NutriSenseBoard Observer2022 — 2026
ColorescienceBoard Member2017 — 2026
Bonafide HealthBoard Observer2015 — 2023
CHC Solutions, Inc.Board Observer2015 — 2023
AktanaBoard Observer2019 — 2023
Capgemini ConsultingSenior Consultant2012 — 2015New York City Metropolitan Area
Insight Strategy AdvisorsAnalyst2011 — 2012New York City Metropolitan Area
StrykerQuality Systems2010

Skills & more

Management Consulting34Strategic Consulting19Consulting17Oncology10Competitive Intelligence7Market Entry6Competitive Analysis6Organizational Design5Market Access3Closed Loop Marketing2Generic Drugs2Business Process Mapping2

+12 more

Health EconomicsCommercializationAnalyticsBusiness TransformationPatent LitigationTarget SegmentationVenture CapitalBusiness DevelopmentMandarinPharmaceutical IndustryStrategyMicrosoft Office

Languages Chinese · Spanish

From Ian's professional profile.

Investments

Board seats

3B ScientificBonafide HealthColorescienceCortiCaremiraDryNutrisenseNutrition 21Seraphina Therapeutics

Per the firm's website.

Colleagues at 1315 Capital

Adele C. Oliva

Founding Partner at 1315 Capital

Brian Schwenk

CFO and CCO at 1315 Capital

Craig Matturro

Principal at 1315 Capital

Jacqueline Akpan

Controller at 1315 Capital

Jake Baker

Business Development Associate at 1315 Capital

Jamie Richardson

Director of Business Development at 1315 Capital

Joe Schlitz

Associate at 1315 Capital

Jordan Brown

Principal at 1315 Capital

Frequently asked questions

Who is Ian B. Li?: Ian Li joined 1315 Capital in 2015 and is a Principal on the investment team. Before moving into investing, he worked as a healthcare management and strategy consultant at Capgemini Consulting and in quality engineering at Stryker Orthopaedics. He holds a BSE in Biomedical Engineering with an Economics minor from Duke University.
Where does Ian B. Li work?: Ian B. Li is Principal at 1315 Capital.
What does Ian B. Li invest in?: Ian B. Li invests in Biotech, Healthtech, Medical Devices.
What boards does Ian B. Li sit on?: Ian B. Li holds tracked board seats at 3B Scientific, Bonafide Health, Colorescience, CortiCare, miraDry, Nutrisense, Nutrition 21, Seraphina Therapeutics.
Where did Ian B. Li go to school?: Ian B. Li studied at Duke University (BSE, Biomedical Engineering, Economics).